Biovail Drug Patent Portfolio
Biovail owns 1 orange book drug protected by 1 US patent Given below is the list of Biovail's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5529791 | Extended release form of diltiazem | 25 Jun, 2013 | Expired |
Biovail's Family Patents
Biovail Drug List
Given below is the complete list of Biovail's drugs and the patents protecting them.
1. Diltiazem Hydrochloride
Diltiazem Hydrochloride is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5529791 | Extended release form of diltiazem |
25 Jun, 2013
(11 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Diltiazem Hydrochloride's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List